Journal of Korean Medical Science

Korean Acad Medical Sciences (대한의학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Features and Outcomes of Microscopic Polyangiitis in Korea

Oh, Ji-Seon;Lee, Chang-Keun;Kim, Yong-Gil;Nah, Seong-Su;Moon, Hee-Bom;Yoo, Bin

  • Published : 2009.04.20
⟨ Previous Next ⟩

Abstract

Microscopic polyangiitis (MPA) is a systemic vasculitis affecting small vessels. To determine the clinical features and outcomes of MPA in Korean patients, we retrospectively reviewed the medical records of patients diagnosed with MPA at a single medical center in Korea between 1989 and 2006. The 18 patients who met the Chapel Hill criteria for MPA had a mean (${\pm}SD$) age at the time of diagnosis of $62.4{\pm}12.7yr$. Renal manifestations and general symptoms were the most common features of MPA, with lung involvement also very common. Antineutrophil cytoplasmic antibodies (ANCA) were present in 17 of the 18 patients (94%). Of 17 patients treated with steroids and cyclophosphamide, 11 (65%) had stable or improved course. One patient treated with steroids without cyclophosphamide showed disease progression. Ten of the 18 patients (56%) died at a median follow-up of 8 months. MPA in Korean patients was distinguished by a higher rate of lung involvement, especially alveolar hemorrhage, which was the leading cause of death in our patients. Korean patients were also older at MPA onset and were more likely positive for ANCA. Other overall clinical manifestations did not differ significantly.

Keywords

References

  1. Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. Q J Med 1948; 17: 175-202.
  2. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McCluskey RT, Sinico RA, Rees AJ, Van Es LA, Waldherr R, Wiik A. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92. https://doi.org/10.1002/art.1780370206
  3. Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 421-30. https://doi.org/10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6
  4. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996; 75: 17-28. https://doi.org/10.1097/00005792-199601000-00003
  5. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87: 671-8.
  6. Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985; 56: 467-83.
  7. Adu D, Howie AJ, Scott DG, Bacon PA, McGonigle RJ, Micheal J. Polyarteritis and the kidney. Q J Med 1987; 62: 221-37.
  8. Pusey CD, Gaskin G. Disease associations with anti-neutrophil cytoplasmic antibodies. Adv Exp Med Biol 1993; 336: 145-55.
  9. Hauschild S, Schmitt WH, Csernok E, Flesch BK, Rautmann A, Gross WL. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 1993; 336: 245-51.
  10. Guillevin L, Visser H, Noel LH, Pourrat J, Vernier I, Gayraud M, Oksman F, Lesavre P. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients. J Rheumatol 1993; 20: 1345-9.
  11. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT, Masi AT, Mills JA, Stevens MB. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088-93. https://doi.org/10.1002/art.1780330805
  12. Bae YD, Choi HJ, Lee JC, Park JJ, Lee YJ, Lee EB, Song YW. Clinical features of polyarteritis nodosa in Korea. J Korean Med Sci 2006; 21: 591-5. https://doi.org/10.3346/jkms.2006.21.4.591
  13. Song BC, Kim SH, Kim H, Ying YH, Kim HJ, Kim YJ, Yoon JH, Lee HS, Cha CY, Kook YH, Kim BJ. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J Med Virol 2005; 76: 194-202. https://doi.org/10.1002/jmv.20354
  14. Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B, French Vasculitis Study Group. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001; 44: 666-75. https://doi.org/10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A
  15. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody- associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 23-32.
  16. Serra A, Cameron JS, Turner DR, Hartley B, Ogg CS, Neild GH, Williams DG, Taube D, Brown CB, Hicks JA. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. Q J Med 1984; 53: 181-207.
  17. D'Agati V, Chander P, Nash M, Mancilla-Jimenez R. Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis 1986; 7: 95-110.

Cited by

  1. Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis vol.49, pp.15, 2010, https://doi.org/10.2169/internalmedicine.49.3135
  2. Mycophenolate Mofetil for Induction and Maintenance of Remission in Microscopic Polyangiitis with Mild to Moderate Renal Involvement-A Prospective, Open-Label Pilot Trial vol.5, pp.3, 2010, https://doi.org/10.2215/cjn.06010809
  3. ANCA Associated Vasculitis vol.17, pp.2, 2009, https://doi.org/10.4078/jkra.2010.17.2.108
  4. Diffuse Alveolar Hemorrhage in a 39-year-old Woman: Unusual Initial Presentation of Microscopic Polyangiitis vol.44, pp.6, 2011, https://doi.org/10.5090/kjtcs.2011.44.6.448
  5. 흉막삼출로 발현된 현미경적 다발혈관염 1예 vol.72, pp.2, 2012, https://doi.org/10.4046/trd.2012.72.2.197
  6. Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea vol.32, pp.10, 2009, https://doi.org/10.1007/s00296-011-2079-4
  7. Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan vol.17, pp.1, 2013, https://doi.org/10.1007/s10157-012-0651-1
  8. ANCA-associated vasculitis: report from Korea vol.17, pp.5, 2009, https://doi.org/10.1007/s10157-012-0754-8
  9. Current Concept and Epidemiology of Systemic Vasculitides vol.63, pp.4, 2014, https://doi.org/10.2332/allergolint.14-rai-0778
  10. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan vol.35, pp.3, 2009, https://doi.org/10.1007/s00296-014-3106-z
  11. Long-term outcome of mycophenolate mofetil treatment for patients with microscopic polyangiitis: an observational study in Chinese patients vol.36, pp.7, 2009, https://doi.org/10.1007/s00296-016-3492-5
  12. Chronic and Asymptomatic Diffuse Alveolar Haemorrhage with Microscopic Polyangiitis: A Case Report and Review of the Literature vol.2016, pp.None, 2009, https://doi.org/10.1155/2016/1658126
  13. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review vol.60, pp.1, 2009, https://doi.org/10.3349/ymj.2019.60.1.10
  14. Clinical role of albumin to globulin ratio in microscopic polyangiitis: a retrospective monocentric study vol.38, pp.2, 2019, https://doi.org/10.1007/s10067-018-4292-y
  15. Shedding light on vasculitis in Egypt: a multicenter retrospective cohort study of characteristics, management, and outcome vol.38, pp.6, 2009, https://doi.org/10.1007/s10067-019-04441-4
  16. Clinical characteristics and outcomes in microscopic polyangiitis patients with renal involvement: a study of 124 Chinese patients vol.20, pp.1, 2009, https://doi.org/10.1186/s12882-019-1535-3
  17. Survival in ANCA-Associated Vasculitides in a Peruvian Center : 28 Years of Experience vol.27, pp.6, 2021, https://doi.org/10.1097/rhu.0000000000001529
  18. Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar haemorrhage and central nervous system vasculitis vol.9, pp.None, 2021, https://doi.org/10.1177/2050313x211011814
  19. Interstitial Lung Disease and Diffuse Alveolar Hemorrhage, the Two Key Pulmonary Manifestations in Microscopic Polyangiitis vol.84, pp.4, 2009, https://doi.org/10.4046/trd.2021.0065
  20. MR imaging findings of musculoskeletal involvement in microscopic polyangiitis: a comparison with inflammatory myopathy vol.126, pp.12, 2021, https://doi.org/10.1007/s11547-021-01407-y
  21. Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review vol.30, pp.162, 2009, https://doi.org/10.1183/16000617.0123-2021